TerminatedNot Applicable

Evaluation of Effectiveness and Safety of Bioresorbable Vascular Scaffold in Routine Clinical Practice

Stopped: Due to stop BVS supply discontinuation

South Korea629 participantsStarted 2016-02-26

Plain-language summary

The purpose of this study is to evaluate the relative effectiveness and safety of Bioresorbable Vascular Scaffold compared to other (drug eluting stents) DES.

Who can participate

Age range19 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 19 and more * Intervention with Bioresorbable Vascular Scaffold * Agreed with written informed consent form Exclusion Criteria: * Bypass graft surgery (CABG) recommended * Lesion with previous bypass graft surgery (CABG) * Severe calcification and/or severe tortuosity * Contraindication to antiplatelet agent or Inability to take dual antiplatelet therapy within 1 year * Life expectancy of 1year and under * Subjects scheduled to receive cardiac surgery or serious non-cardiac surgery * Cardiac shock

What they're measuring

Composite event

Timeframe: 1 year

Trial details

NCT IDNCT02622100

SponsorDuk-Woo Park, MD

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-03-23

View on ClinicalTrials.gov More Arterial Occlusive Diseases trials